ITGAM and rheumatoid arthritis: Whereas CD90, HLA-DR, CD64, and CD29 preferentially identified patients with mild current activity (RA(+)), CD64 and CD11b indicated high current activity and are therefore suitable markers to differentiate between RA(++) and control (Additional file 1, Table S2).